Pixelgen Technologies was founded on the principle that understanding how proteins move and relocate across the cell membrane is critical to better understanding cell activity and enables new insights into drug development. The company has developed Molecular Pixelation (MPX), the first technology to capture the dynamic changes that occur with the cell surface proteome at such a high multiplexed level on thousands of cells simultaneously without the use of a microscope but a sequencing machine.